(Q43512589)

24 November 2017

title

The small molecule FKBP ligand GPI 1046 induces partial striatal re-innervation after intranigral 6-hydroxydopamine lesion in rats (English)

1 reference

24 November 2017

1 reference

Ross DT

1

1 reference

24 November 2017

Guo H

2

1 reference

24 November 2017

Howorth P

3

1 reference

24 November 2017

Chen Y

4

1 reference

24 November 2017

Hamilton GS

5

1 reference

24 November 2017

Steiner JP

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

297

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

113-116

1 reference

Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

Immunophilins: beyond immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

Analysis of the neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

Dopaminergic responses to striatal damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

The neuropathologic basis of different clinical subgroups of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

High brain densities of the immunophilin FKBP colocalized with calcineurin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901683-9

7 January 2021

10.1016/S0304-3940(00)01683-9

Identifiers

DOI

1 reference

24 November 2017

1 reference